We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Microsoft, Facebook, UnitedHealth, Mastercard and ExxonMobil
Read MoreHide Full Article
For Immediate Release
Chicago, IL –February 5, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft (MSFT - Free Report) , Facebook , UnitedHealth (UNH - Free Report) , Mastercard (MA - Free Report) and ExxonMobil (XOM - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Microsoft, Facebook and UnitedHealth
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft, Facebook and UnitedHealth. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
Microsoft’s shares have lost 5% in the past six months, underperforming the Zacks Computer Software industry’s decline of 1.7% during the same period. Microsoft reported modest second-quarter results. Notably, both top and bottom line increased year over year.
Robust execution and better-than-expected demand from customers for hybrid cloud offerings drove the quarterly results. The Zacks analyst thinks Microsoft is benefiting from growing user base of its different applications like Office 365 commercial, Dynamics, Outlook mobile and Teams.
Moreover, Azure’s expanding customer base is a key catalyst. Microsoft’s gaming segment is performing well, primarily driven by a combination of Xbox Live, Game Pass subscriptions and Mixer, which are driving user engagement. Further, acquisitions like PlayFab and GitHub expand Microsoft’s TAM and penetration.
However, projections of a moderating growth rate in commercial cloud gross margin, and OEM Pro and Windows commercial businesses is a headwind. Also, competition is stiff and its dominant position in the PC market continues to be challenged.
Shares of Buy-ranked Facebook have outperformed the S&P 500 index over the past three months, gaining +11.4% vs. -0.7%. Facebook reported impressive fourth-quarter 2018 results, driven by solid ad revenues that benefited from impression growth on both Instagram Stories and Feed.
But the Zacks analyst thinks only Instagram Stories is likely to be the key catalyst for impression growth in 2019. Facebook needs to improve ad pricing to drive top-line growth. Further, the company’s plan to introduce commerce in Instagram is expected to be a major growth driver. Additionally, the company’s plan to integrate messaging apps — WhatsApp, Instagram, and Messenger – is expected to take time (not before 2020).
Management believes that the integration will boost user experience by making the services more secure through end-to-end encryption. However, continued mix shift toward Stories is expected to hurt ARPU.
Strong Buy-ranked UnitedHealth’s shares have performed nearly in-line with the Zacks Medical Insurance industry's rally in the past year (up +22.1% vs. +22.5%). UnitedHealth Group’s fourth-quarter 2018 earnings of $3.28 per share beat expectations by 2.5% and increased 27% year over year.
Higher revenues, strength in both segments — UnitedHealthcare and Optum — plus membership growth led to this outperformance. The Zacks analyst likes UnitedHealth’s balance sheet strength, strong operating performance, favorable business profile and solid enterprise risk management. Increased earnings from operations are being driven by higher revenues, appropriate pricing, good medical cost management and operational efficiencies.
The company also benefits from services, technology and innovations from its segment Optum. However, slowdown of growth in international operations, Commercial and Medicare, Part D stand-alone membership, increase in leverage and interest burden and medical care ratio are some headwinds.
Other noteworthy reports we are featuring today include Mastercard and ExxonMobil.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1% and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Microsoft, Facebook, UnitedHealth, Mastercard and ExxonMobil
For Immediate Release
Chicago, IL –February 5, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Microsoft (MSFT - Free Report) , Facebook , UnitedHealth (UNH - Free Report) , Mastercard (MA - Free Report) and ExxonMobil (XOM - Free Report) .
Here are highlights from Monday’s Analyst Blog:
Top Stock Reports for Microsoft, Facebook and UnitedHealth
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft, Facebook and UnitedHealth. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Microsoft’s shares have lost 5% in the past six months, underperforming the Zacks Computer Software industry’s decline of 1.7% during the same period. Microsoft reported modest second-quarter results. Notably, both top and bottom line increased year over year.
Robust execution and better-than-expected demand from customers for hybrid cloud offerings drove the quarterly results. The Zacks analyst thinks Microsoft is benefiting from growing user base of its different applications like Office 365 commercial, Dynamics, Outlook mobile and Teams.
Moreover, Azure’s expanding customer base is a key catalyst. Microsoft’s gaming segment is performing well, primarily driven by a combination of Xbox Live, Game Pass subscriptions and Mixer, which are driving user engagement. Further, acquisitions like PlayFab and GitHub expand Microsoft’s TAM and penetration.
However, projections of a moderating growth rate in commercial cloud gross margin, and OEM Pro and Windows commercial businesses is a headwind. Also, competition is stiff and its dominant position in the PC market continues to be challenged.
(You can read the full research report on Microsoft here >>>).
Shares of Buy-ranked Facebook have outperformed the S&P 500 index over the past three months, gaining +11.4% vs. -0.7%. Facebook reported impressive fourth-quarter 2018 results, driven by solid ad revenues that benefited from impression growth on both Instagram Stories and Feed.
But the Zacks analyst thinks only Instagram Stories is likely to be the key catalyst for impression growth in 2019. Facebook needs to improve ad pricing to drive top-line growth. Further, the company’s plan to introduce commerce in Instagram is expected to be a major growth driver. Additionally, the company’s plan to integrate messaging apps — WhatsApp, Instagram, and Messenger – is expected to take time (not before 2020).
Management believes that the integration will boost user experience by making the services more secure through end-to-end encryption. However, continued mix shift toward Stories is expected to hurt ARPU.
(You can read the full research report on Facebook here >>>).
Strong Buy-ranked UnitedHealth’s shares have performed nearly in-line with the Zacks Medical Insurance industry's rally in the past year (up +22.1% vs. +22.5%). UnitedHealth Group’s fourth-quarter 2018 earnings of $3.28 per share beat expectations by 2.5% and increased 27% year over year.
Higher revenues, strength in both segments — UnitedHealthcare and Optum — plus membership growth led to this outperformance. The Zacks analyst likes UnitedHealth’s balance sheet strength, strong operating performance, favorable business profile and solid enterprise risk management. Increased earnings from operations are being driven by higher revenues, appropriate pricing, good medical cost management and operational efficiencies.
The company also benefits from services, technology and innovations from its segment Optum. However, slowdown of growth in international operations, Commercial and Medicare, Part D stand-alone membership, increase in leverage and interest burden and medical care ratio are some headwinds.
(You can read the full research report on UnitedHealth here >>>).
Other noteworthy reports we are featuring today include Mastercard and ExxonMobil.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1% and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.